Login

Switch On Your HIV Smarts.

Is this the end of gay bars in San Francisco?

Is this the end of gay bars in San Francisco?

February 27, 2017, by

Cirrus contemplates the “gay” bars appealing to mixed crowds, the changing make-up of the Castro, and the more fluid gender and sexual identities of younger LGBT people. Read More

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

February 24, 2017, by

Two new HIV drugs, an NNRTI and an integrase inhibitor, did well in clinical trials and are currently being tested as part of fixed-dose co-formulated pills. Read More

“I’ve heard of hairy palms, but a hairy tongue?!” HIV & oral health concerns

February 23, 2017, by

Caroline Shiboski, DDS, PhD gives good advice about the health conditions that people living with HIV should watch out for in their mouths, and what to do if they notice something abnormal. Read More

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

February 22, 2017, by

People taking only two drugs, dolutegravir and rilpivirine, maintained viral suppression in participants of the SWORD-1 an SWORD-2 studies. Read More

Research will see if antibodies can more selectively target & kill HIV-infected cells

Research will see if antibodies can more selectively target & kill HIV-infected cells

February 20, 2017, by

In this Q&A, Galit Alter, PhD explains her research on broadly functional antibodies and if they can be used to rid the body of the latent HIV reservoir. Read More